Teva FDA Wednesday, June 19, 2002 0.00 Neutral

FDA Approves TRAMADOL HYDROCHLORIDE — Teva Pharmaceuticals USA, Inc.

Teva Pharmaceuticals USA, Inc. received FDA approval for generic Tramadol Hydrochloride tablets, a development likely to intensify generic competition and pressure pricing within the pain management market.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day